I don't think we're looking at months".
The questionnaire was administered at months 6 and 18.
Follow-up visits were scheduled at months 1, 3, 5, and 12 after inclusion.
Patients with macular edema at months 3 and 6 in different study groups.
Follow-up visits were every 2 weeks to week 10 and then at months 4, 6, 9 and 12.
The prophylaxis group, compared with the withdrawal group, showed significantly more pronounced reductions in total headache index at months 3 and 12, and in sick leave days/month at months 5 and 12.
The primary outcome is episodic memory as measured by the Hopkins Verbal Learning Test Revised at baseline and at months 3, 12, 18, and 24.
At months 0 and 9, total cholesterol, HDL and LDL cholesterol, and triglycerides were investigated.
Multivariate analysis was performed on all remaining peaks, to test for associations with disease-free survival at months 4 and 8, and survival at months 8 and 12.
For the progressively mild trajectory, the predicted value underestimated the observed value at months 8 and 1 and overestimated the observed value at months 5, 4, and 3.
However, significant differences for this endpoint were demonstrated at months 1, 2 and 3 in patients with BRVO, and at months 1 and 2 for patients with CRVO.
